Rothschild & CO Asset Management Us Inc. Care Dx, Inc. Transaction History
Rothschild & CO Asset Management Us Inc.
- $6.56 Billion
- Q4 2022
A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 266,132 shares of CDNA stock, worth $6.01 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
266,132
Previous 284,227
6.37%
Holding current value
$6.01 Million
Previous $4.84 Million
37.25%
% of portfolio
0.05%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding CDNA
# of Institutions
161Shares Held
53.5MCall Options Held
60.8KPut Options Held
34.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.7MShares$129 Million0.81% of portfolio
-
Black Rock Inc. New York, NY5.29MShares$119 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$99 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.91MShares$88.4 Million1.02% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.58MShares$58.2 Million0.03% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.21B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...